Sutro Biopharma STRO Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $73.68M-30.6% | $58.13M-69.5% | $65.93M-62.2% | $64.03M-29.5% | $106.23M+62.9% | ||
| $128.88M-9.7% | $83.3M-34.2% | $101.67M-52.4% | $141.11M-50.5% | $142.74M-29.5% | ||
| $12.48M-7.9% | $3.98M-53.8% | $3.92M-41.1% | $8M+15.1% | $13.56M-56.7% | ||
| $220.97M-23.1% | $150.93M-56.0% | $182.11M-55.1% | $231.63M-47.8% | $287.41M-18.9% | ||
| $9.36M-44.3% | $10.65M-41.5% | $13.35M-29.7% | $14.98M-22.8% | $16.8M-18.6% | ||
| $241.99M-24.7% | $173.83M-55.1% | $209.66M-53.6% | $262.36M-46.4% | $321.43M-20.3% | ||
| $5.49M-32.9% | $7.57M-27.8% | $7.03M+13.2% | $4.31M-29.2% | $8.18M+8.9% | ||
| $9.4M-86.4% | $10.56M-84.9% | $8.98M-87.6% | $11.96M-83.8% | $68.98M+236% | ||
| $70.81M-46.8% | $75.13M-43.0% | $71.9M-45.2% | $74.25M-42.9% | $133.05M+67.3% | ||
| $308.88M-11.0% | $306.28M-10.6% | $296.93M-12.8% | $294.47M-12.6% | $347.24M+13.7% | ||
| $17K-79.8% | $9K+12.5% | $85K+3.7% | $85K+3.7% | $84K+35.5% | ||
| -$1.02B-17.8% | -$977.96M-24.3% | -$931.19M-30.3% | -$874.34M-31.4% | -$862.84M-39.7% | ||
| -$66.89M-159% | -$132.45M-397% | -$87.27M-178% | -$32.11M-121% | -$25.81M-126% | ||
| $241.99M-24.7% | $173.83M-55.1% | $209.66M-53.6% | $262.36M-46.4% | $321.43M-20.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Sutro Biopharma's total assets?
- Sutro Biopharma (STRO) holds $242.0M in total assets, down 24.7% year over year.
- How much debt does Sutro Biopharma have?
- Sutro Biopharma carries $13.6M in total debt against -$66.9M of shareholders' equity, a debt-to-equity ratio of 0.52.
- How much cash does Sutro Biopharma have?
- Sutro Biopharma holds $73.7M in cash and equivalents.
- Can Sutro Biopharma cover its short-term obligations?
- Its current ratio is 3.12 — current assets exceed current liabilities.
- Where does Sutro Biopharma's balance sheet data come from?
- Every line is extracted from Sutro Biopharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
